Seifer DB, Maclaughlin DT. Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. Fertil Steril 2007;88(3):539-46.
DOI: 10.1016/j.fertnstert.2007.02.014
Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update 2014;20(3):370-85.
DOI: 10.1093/humupd/dmt062
Vrzáková R, Šimánek V, Topolčan O, Vurm V, Slouka D, Kučera R. The Stability of the Anti-Müllerian Hormone in Serum and Plasma Samples under Various Preanalytical Conditions. Diagnostics 2023;13(8):1501.
DOI: 10.3390/diagnostics13081501
Kotlyar AM, Seifer DB. Ethnicity/Race and Age-Specific Variations of Serum AMH in Women-A Review. Front Endocrinol (Lausanne) 2021;9(11):593216.
Bhide P, Timlick E, Kulkarni A, Gudi A, Shah A, Homburg R, et al. Effect of cigarette smoking on serum anti-Mullerian hormone and antral follicle count in women seeking fertility treatment: a prospective cross-sectional study. BMJ Open 2022;12(3):e049646.
DOI: 10.1136/bmjopen-2021-049646
Overbeek A, Broekmans FJ, Hehenkamp WJ, Wijdeveld ME, Van Disseldorp J, Van Dulmen-den Broeder E, et al. Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis. Reprod Biomed Online 2012;24(6):664-9.
DOI: 10.1016/j.rbmo.2012.02.023
Gorkem U, Kucukler FK, Togrul C, Gungor T. Anti‐Müllerian hormone exhibits a great variation in infertile women with different ovarian reserve patterns. Aust NZ J Obstet Gyn 2017;57(4):464-8.
DOI: 10.1111/ajo.12625
Siddiqui QA, Anjum S, Zahra F, Yousuf SM. Ovarian reserve parameters and response to controlled ovarian stimulation in infertile patients. Pak J Med Sci 2019;35(4):958-62.
DOI: 10.12669/pjms.35.4.753
Rudnicka E, Kunicki M, Calik-Ksepka A, Suchta K, Duszewska A, Smolarczyk K, et al. Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS. Int J Mol Sci 2021;22(22):12507.
DOI: 10.3390/ijms222212507
Pacchiarotti A, Frati P, Milazzo GN, Catalano A, Gentile V, Moscarini M. Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis. Eur J Obst Gynecol Reprod Biol 2014;172:62-4.
DOI: 10.1016/j.ejogrb.2013.10.003
Henao-Ochoa C, Lasprilla-Tovar JD, Alfaro-Velásquez JM, Campuzano-Maya G. Clinical utility of the measurement of the Anti-müllerian hormone in women. Medicina & Laboratorio 2017;23:213-36.
DOI: 10.36384/01232576.37
Moolhuijsen L, Visser J. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab 2020;105(11):3361-73.
DOI: 10.1210/clinem/dgaa513
Leader B, Baker VL. Maximizing the clinical utility of antimüllerian hormone testing in women’s health. Curr Opin Obstet Gynecol 2014;26(4):226-36.
DOI: 10.1097/GCO.0000000000000087
Zhang Y, Wang L, Zhao S, Zhang C, He Q, Liao A. Predictive value of anti-Müllerian hormone on pregnancy outcomes in in-vitro fertilization/intracytoplasmic single sperm injection patients at different ages. Arch Gynecol Obstet 2021;304(6):1611-20.
DOI: 10.1007/s00404-021-06108-5